Anteris Technologies Global (NASDAQ:AVR) Announces Earnings Results, Misses Expectations By $0.05 EPS

Anteris Technologies Global (NASDAQ:AVRGet Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.05), Zacks reports. The business had revenue of $0.43 million during the quarter, compared to analysts’ expectations of $0.74 million.

Anteris Technologies Global Price Performance

Anteris Technologies Global stock opened at $3.79 on Friday. Anteris Technologies Global has a one year low of $2.34 and a one year high of $8.79. The firm has a market capitalization of $145.57 million and a P/E ratio of -3.18. The business has a fifty day moving average price of $4.72 and a 200-day moving average price of $4.21.

Institutional Investors Weigh In On Anteris Technologies Global

A number of institutional investors and hedge funds have recently modified their holdings of AVR. JPMorgan Chase & Co. boosted its holdings in Anteris Technologies Global by 9,958.6% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock valued at $4,049,000 after purchasing an additional 1,057,707 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Anteris Technologies Global by 85.1% during the 3rd quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock worth $3,355,000 after acquiring an additional 342,711 shares during the last quarter. Geode Capital Management LLC increased its stake in Anteris Technologies Global by 154.3% in the second quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock valued at $1,593,000 after acquiring an additional 255,088 shares during the last quarter. Nantahala Capital Management LLC lifted its stake in Anteris Technologies Global by 1.8% during the second quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company’s stock worth $6,419,000 after purchasing an additional 30,000 shares during the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of Anteris Technologies Global during the 1st quarter valued at about $32,000.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a research note on Thursday, October 30th. Four investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $16.50.

Check Out Our Latest Analysis on AVR

About Anteris Technologies Global

(Get Free Report)

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.

Recommended Stories

Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.